Global Cord Blood | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Oasis Management Company Ltd.(10.1%),Seth Fischer(10.1%)
Global Cord Blood | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Oasis Management Company Ltd.(9.91%),Seth Fisher(9.91%)
Global Cord Blood | SC 13G: Statement of acquisition of beneficial ownership by individuals-Oasis Management Company Ltd.(5.59%),Seth Fisher(5.59%)
Global Cord Blood | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jayhawk Capital Management, L.L.C.(4.7%),AMC Fund. L.P.(4.7%), etc.
Global Cord Blood | SC 13G: Statement of acquisition of beneficial ownership by individuals-PAGAC III Holding VII Limited(7.8%),PAG Asia I LP(7.8%), etc.
Global Cord Blood | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yafei Yuan(67.1%),Sanpower Group Co., Ltd.(67.1%), etc.
Global Cord Blood | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yafei Yuan(67.1%),Sanpower Group Co., Ltd.(67.1%), etc.
Global Cord Blood | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yafei Yuan(67.1%),Sanpower Group Co., Ltd.(67.1%), etc.
Global Cord Blood | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yafei Yuan(67.1%),Sanpower Group Co., Ltd.(67.1%), etc.
Global Cord Blood | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yafei Yuan(67.1%),Sanpower Group Co., Ltd.(67.1%), etc.
Global Cord Blood | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yafei Yuan(67.1%),Sanpower Group Co., Ltd.(67.1%), etc.
Global Cord Blood | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Golden Meditech Stem Cells (BVI) Company Limited(64.9%),Magnum Opus International Holdings Limited(64.9%), etc.
Global Cord Blood | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Blue Ocean Structure Investment Co Ltd(65.4%),Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership)(65.4%), etc.
Global Cord Blood | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Blue Ocean Structure Investment Co Ltd(65.4%),Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership)(65.4%), etc.
Global Cord Blood | SC 13D: Statement of acquisition of beneficial ownership by individuals-Golden Meditech Stem Cells (BVI) Company Limited(64.9%),Magnum Opus International Holdings Limited(64.9%), etc.
Global Cord Blood | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Blue Ocean Structure Investment Co Ltd(65.4%),Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership)(65.4%), etc.
Global Cord Blood | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Blue Ocean Structure Investment Co Ltd(65.4%),Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership)(65.4%), etc.
Global Cord Blood | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Blue Ocean Structure Investment Co., Ltd.(65.4%),Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership)(65.4%), etc.
Global Cord Blood | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kent C. McCarthy(6.27%),Jayhawk Capital Management, L.L.C.(3.13%), etc.
Global Cord Blood | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
No Data